Skip to main content
SpringerLink
Log in

Human Papillomavirus

  • Chapter
Molecular Diagnostics

  • 6028 Accesses

Abstract

Once the most common cause of cancer death in women in the United States, the incidence and mortality rates from cervical cancer declined dramatically with the introduction of the Papanicolaou (Pap) smear. Absence of such screening programs in many developing countries, however, is the most significant factor responsible for the high incidence and mortality rates of this cancer. Excluding the common skin cancers, cervical cancer remains the second most common cancer in women worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics 2001. CA Cancer J. Clin. 50:7–33, 2001.

    Article  Google Scholar 

  2. Boffeta, P. and Parkin, D. M. Cancer in developing countries. CA Cancer J. Clin. 44:81–90, 1994.

    Article  Google Scholar 

  3. Adam, E., Berkova, Z., Daxnerova, Z., Icenogle, J., Reeves, W. C., and Kaufman, R. H. Papillomavirus detection: demographic and behavioral characterisitics influencing the identification of cervical disease. Am. J. Obstet. Gynecol. 182:257–264, 2000.

    Article  CAS  PubMed  Google Scholar 

  4. Wallin, K. L., Wiklund, F., Angstrom, T., et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N. Engl. J. Med. 341:1633–1638, 1999.

    Article  CAS  PubMed  Google Scholar 

  5. Kaufman, R. H., Adam, E., and Vonka, V. Human papillomavirus infection and cervical carcinoma. Clin. Obstet. Gynecol. 43:363–380, 2000.

    Article  CAS  PubMed  Google Scholar 

  6. Stoler, M. H. Human papillomavirus biology and cervical neoplasia. Arch. Pathol. Lab. Med. 127:935–939, 2003.

    PubMed  Google Scholar 

  7. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., et al. The HPV16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495–505, 1993.

    Article  CAS  PubMed  Google Scholar 

  8. Chellappan, S., Kraus, V. B., Kroger, B., et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA. 89:4549–4553, 1992.

    Article  CAS  PubMed  Google Scholar 

  9. Choo, K. B., Pan, C. C., and Han, S. H. Integration of human papil-lomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 161:259–261, 1987.

    Article  CAS  PubMed  Google Scholar 

  10. Munoz, N., Bosch, F. X., de Sanjose, S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518–527, 2003.

    Article  PubMed  Google Scholar 

  11. Jemal, A., Thomas, A., Murray, T., and Thun, M. Cancer statistics, 2002. CA Cancer J. Clin. 52:23–47, 2002.

    Article  PubMed  Google Scholar 

  12. Bastian, L., Datta, S., Hasselblad, V., Hickey, J., Myers, E., and Nanda, K. Evaluation of Cervical Cytology. Evidence Report/ Technology Assessment Number 5. Department. of Health and Human Services, Agency for Health Care Policy and Research, Bethesda, MD, 1999.

    Google Scholar 

  13. Papillo, J. L., Zarka, M. A., and St. John, T. L. Evaluation of the ThinPrep Pap Test in clinical practice. A seven-month, 16,314-case experience in northern Vermont. Acta Cytol. 42:203–208, 1998.

    CAS  PubMed  Google Scholar 

  14. Diaz-Rosario, L. A. and Kabawat, S. E. Performance of a fluid-based, thin layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Arch. Pathol. Lab. Med. 123:817–821, 1999.

    CAS  PubMed  Google Scholar 

  15. Weintraub, J. and Morabia, A. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer. Diagn. Cytopathol. 22:52–59, 2000.

    Article  CAS  PubMed  Google Scholar 

  16. Linder, J. and Zahniser, D. ThinPrep Pap testing to reduce false-negative cytology. Arch. Pathol. Lab. Med. 122:139–144, 1998.

    CAS  PubMed  Google Scholar 

  17. Hutchinson, M. L., Zahniser, D. J., Sherman, M. E., et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 87:48–55, 1999.

    Article  CAS  PubMed  Google Scholar 

  18. Solomon, D., Davey, D., Kurman, R., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114–2119, 2002.

    Article  PubMed  Google Scholar 

  19. Schiffmann, M. and Castle, P. E. Human papillomavirus: epidemiology and public health. Arch. Pathol. Lab. Med. 127:930–934, 2003.

    Google Scholar 

  20. Moscicki, A. B., Shiboski, S., Broering, J., et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J. Pediatr. 132:277–284, 1998.

    Article  CAS  PubMed  Google Scholar 

  21. Ho, G. Y., Bierman, R., Beardsley, L., et al. Natural history of cer-vicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423–428, 1998.

    Article  CAS  PubMed  Google Scholar 

  22. Manos, M. M., Kinney, W. K., Hurley, L. B., et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281:1605–1610, 1999.

    Article  CAS  PubMed  Google Scholar 

  23. Shiffman, M. and Solomon, D. Findings to date from the ASCUS-LSIL triage study (ALTS). Arch. Pathol. Lab. Med. 127:946–949, 2003.

    Google Scholar 

  24. Solomon, D., Schiffman, M., Tarone, R., et al. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J. Natl. Cancer Inst. 93:293–299, 2001.

    Article  CAS  PubMed  Google Scholar 

  25. The ALTS Group. HPV testing as a triage strategy for women with cytologic evidence of low grade squamous intraepithelial lesions: early results from a randomized trial on the clinical management of ASCUS and LSIL cytologic abnormalities. J. Natl. Cancer Inst. 92:397–402, 2000.

    Article  Google Scholar 

  26. Stoler, M. H., Schiffman, M. for the ALTS Group. Interobserver reproducibility of cervical cytologic and histologic diagnoses: realistic estimates from the ASCUS-LSIL Triage Study (ALTS). JAMA 285:1500–1505, 2001.

    Article  CAS  PubMed  Google Scholar 

  27. Richart, R. M. and Lorincz, A. T. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch. Pathol. Lab. Med. 127:959–968, 2003.

    PubMed  Google Scholar 

  28. Saslow, D., Runowicz, C. D., Solomon, D., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J. Clin. 52:342–362, 2002.

    Article  PubMed  Google Scholar 

  29. Wright, T. C., Cox, J. T., and Massad, L. S., for the ASCCP-spon-sored Consensus Conference. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 287:2120–2126, 2002.

    Article  PubMed  Google Scholar 

  30. Cox, J. T. Clinical role of HPV testing. Obstet. Gynecol. Clin. North Am. 23:811–851, 1996.

    Article  CAS  PubMed  Google Scholar 

  31. Paraskevaidis, E., Koliopoulos, F., Alamanos, Y., Malamou-Mitsi, V., Lolis, C. D., and Kitchener, H. C. Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia. Obstet. Gynecol. 98:833–836, 2001.

    Article  CAS  PubMed  Google Scholar 

  32. Hubbard, R. A. Human papillomavirus testing methods. Arch. Pathol. Lab. Med. 127:940–945, 2003.

    CAS  PubMed  Google Scholar 

  33. Schiffman, M. N., Bauer, H. M., Lorincz, A., et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J. Clin. Microbiol. 29:573–577, 1991.

    CAS  PubMed  Google Scholar 

  34. Caussy, D., Orr, W., Daya, A. D., Roth, P., Reeves, W., and Rawls, W. Evaluation of methods for detecting human papillomavirus deoxyribonucleotide sequences in clinical specimens. J. Clin. Microbiol. 26:236–243, 1988.

    CAS  PubMed  Google Scholar 

  35. Bekkers, R. L., Melchers, W. J., Bulten, J., et al. Localized distribution of human papillomavirus genotypes in the uterine cervix. Eur. J. Gynaecol. Oncol. 23:203–206, 2002.

    CAS  PubMed  Google Scholar 

  36. Huang, C. C., Qiu, J. T., Kshima, M. L., Kurman, R. J., and Wu, T. C. Generation of type specific probes for the detection of single copy human papillomavirus by a novel in situ hybridization method. Mod. Pathol. 11:971–977, 1998.

    CAS  PubMed  Google Scholar 

  37. Bolick, D. R. Laboratory implementation of human papillomavirus testing. Arch. Pathol. Lab. Med. 127:984–990, 2003.

    PubMed  Google Scholar 

  38. Clavel, C., Massure, M., Bory, J. P., et al. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect in routine high grade cervical lesions: a preliminary study on 1518 women. Br. J. Cancer 80:1306–1311, 1999.

    Article  CAS  PubMed  Google Scholar 

  39. Husnjak, K., Grce, M., Magdic, L., and Paveliae, K. Comparison of five different polymerase chain reaction methods for the detection of human papillomavirus in cervical cell specimens. J. Virol. Methods 88:125–134, 2000.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT, USA

    Theresa M. Voytek

Authors
  1. Theresa M. Voytek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregory J. Tsongalis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA

    William B. Coleman

  2. Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA

    Gregory J. Tsongalis

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Voytek, T.M., Tsongalis, G.J. (2006). Human Papillomavirus. In: Coleman, W.B., Tsongalis, G.J. (eds) Molecular Diagnostics. Humana Press. https://doi.org/10.1385/1-59259-928-1:447

Download citation

  • DOI: https://doi.org/10.1385/1-59259-928-1:447

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-356-5

  • Online ISBN: 978-1-59259-928-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation